Topics

Teva Recalls More Tainted Blood Pressure Drugs

20:00 EDT 29 Apr 2019 | BioSpace

Teva Pharmaceuticals recalled 35 lots of bulk Losartan Potassium after a known carcinogen was discovered in the active pharmaceutical ingredient.

Original Article: Teva Recalls More Tainted Blood Pressure Drugs

NEXT ARTICLE

More From BioPortfolio on "Teva Recalls More Tainted Blood Pressure Drugs"

Quick Search

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...